Related Experiment Video
Updated: Dec 28, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes
Hendawy Om1, Mehrez E El-Naggar2, Mona El-Banna3
1Faculty of Pharmacy, Jouf University, Saudi Arabia-Lecturer of Clinical Pharmacology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
This study developed Diosmin nanoparticles (DSN-NPs) using hydroxypropyl starch (HPS) and Poly lactide-glycolide-chitin (PLGA/chitin) to improve bioavailability for treating diabetic atherosclerosis. DSN-NPs, particularly PLGA/chitin, effectively counteracted diabetes-induced atherosclerosis factors.
Area of Science:
- Pharmacology
- Biotechnology
- Cardiovascular Research
Background:
- Diabetes mellitus with poor glycemic control significantly elevates the risk of atherosclerotic cardiovascular diseases.
- Diosmin (DSN), a citrus flavonoid, possesses antioxidant, anti-hyperglycemic, and anti-inflammatory properties beneficial for cardiovascular health.
- DSN's poor water solubility limits its oral absorption and therapeutic efficacy.
Purpose of the Study:
- To enhance the bioavailability and solubility of Diosmin (DSN) by formulating it into nanoparticles (DSN-NPs).
- To evaluate the efficacy of DSN-NPs loaded onto hydroxypropyl starch (HPS) and Poly lactide-glycolide-chitin (PLGA/chitin) in counteracting diabetes-induced atherosclerosis.
Main Methods:
- Diosmin nanoparticles (DSN-NPs) were prepared using emulsion-solvent evaporation and acid-base neutralization methods.
- Nanoparticles were loaded onto polymeric matrices: hydroxypropyl starch (HPS) and Poly lactide-glycolide-chitin (PLGA/chitin).
- The study involved 50 rats divided into five groups, including normal, diabetic, and diabetic rats treated with oral DSN, DSN-HPS, or DSN-PLGA/chitin, with extensive biochemical analyses.
Main Results:
- Both DSN-HPS and DSN-PLGA/chitin formulations showed statistically significant improvements compared to oral DSN treatment.
- DSN-PLGA/chitin nanoparticles demonstrated a superior ability to counteract atherosclerosis factors induced by diabetes.
- Biochemical markers including lipids, insulin, MDA, NO, PAI-1, PON1, TGF-β1, NF-ҡB, and Ang II were significantly modulated by the DSN-NP treatments.
Conclusions:
- Loading Diosmin onto polymeric nanoparticles, specifically PLGA/chitin, significantly enhances its bioavailability and therapeutic potential against diabetic atherosclerosis.
- DSN-NPs offer a promising strategy for managing atherosclerotic cardiovascular complications associated with diabetes.
- The PLGA/chitin matrix provides a highly effective delivery system for Diosmin in combating diabetes-related vascular damage.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management

